XOMA to Announce First Quarter 2013 Financial Results and Host Webcast on May 8 Apr 25, 2013 8:01am EDT
XOMA Announces Clinical Study Investigating Gevokizumab in Patients With Non-Infectious Anterior Scleritis Has Opened for Enrollment at the National Eye Institute Apr 10, 2013 8:00am EDT
XOMA Appoints Tom Klein to Newly Created Position of Chief Commercial Officer Mar 18, 2013 1:00pm EDT
XOMA Reports 2012 Operational Highlights and Fourth Quarter and Full-Year Financial Results Mar 12, 2013 4:05pm EDT
XOMA Announces Fourth Quarter and Full-Year Financial Results Conference Call Mar 04, 2013 1:30pm EST
XOMA Announces Encouraging Interim Results From Gevokizumab Phase 2 Study for Moderate to Severe Acne Vulgaris Jan 07, 2013 8:00am EST
XOMA Selects Non-Infectious Anterior Scleritis as Next Indication in Gevokizumab Proof-of-Concept Program Dec 31, 2012 8:00am EST
